vimarsana.com

அலுவலகம் ஆஃப் ஆராய்ச்சி உள்கட்டமைப்பு ப்ரோக்ர்யாம்ஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Fannin Innovation Studio Awarded $2,000,000 NIH Grant for Development of a Novel Antivenom Therapeutic Based on Next-Generation Aptamers

New COVID-19 vaccine candidate provides effective option for low- to mid-income countries

New COVID-19 vaccine candidate provides effective option for low- to mid-income countries
eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.

SNPRC at Texas Biomed awarded $37 million NIH grant to continue operations into 2026

SNPRC at Texas Biomed awarded $37 million NIH grant to continue operations into 2026 The Southwest National Primate Research Center (SNPRC) at Texas Biomedical Research Institute (Texas Biomed) has been awarded more than $37 million from the National Institutes of Health (NIH) to continue operations into 2026. The P51 grant, given by the NIH Office of Research Infrastructure Programs, provides essential funding to house and care for nearly 2,500 non-human primates that are part of life-science research programs at Texas Biomed and partners around the globe. Non-human primates play an essential role in pre-clinical research, including most recently helping to show that the Pfizer-BioNTech COVID-19 vaccine would be safe and effective for humans, accelerating the clinical trials. The support from NIH for our Center will ensure that we can continue this critical work in finding new treatments and vaccines against a variety of infectious diseases, while maintaining the absolute highest

New combination immunotherapy plus ART expand innate cells critical to controlling HIV

Yerkes NPRC/Emory University and Institut Pasteur researchers have determined adding a combination immunotherapy to antiviral therapy (ART) is effective in generating highly functional natural killer (NK) cells that can help control and reduce simian immunodeficiency virus (SIV) in animal models. This finding is key for reducing reliance on ART and developing additional treatment options to control HIV/AIDS.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.